BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37272100)

  • 41. A dual-process of targeted and unbiased Nanopore sequencing enables accurate and rapid diagnosis of lower respiratory infections.
    Guo Y; Li Z; Li L; Li S; Sun L; Yang X; Dai Y; Gu J; Yang L; Liu X; Lu B; Han J; Chang K; Gu L; Yin Y; Sun S; Jing C; Chen H; Liu M; Xu H; Liu R; Ren Y; Guo H; Wang H
    EBioMedicine; 2023 Dec; 98():104858. PubMed ID: 37925777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection and Quantification of Mycobacterium tuberculosis in the Sputum of Culture-Negative HIV-infected Pulmonary Tuberculosis Suspects: A Proof-of-Concept Study.
    Madico G; Mpeirwe M; White L; Vinhas S; Orr B; Orikiriza P; Miller NS; Gaeddert M; Mwanga-Amumpaire J; Palaci M; Kreiswirth B; Straight J; Dietze R; Boum Y; Jones-López EC
    PLoS One; 2016; 11(7):e0158371. PubMed ID: 27391604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical significance of in-house metagenomic next-generation sequencing for bronchoalveolar lavage fluid diagnostics in patients with lower respiratory tract infections.
    Li S; Qin J; Zhou P; Peng M; Qian J; Cai Y; Shi Q; Tung TH; Shen B; Yu S
    Front Cell Infect Microbiol; 2022; 12():961746. PubMed ID: 36590589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis.
    Tueller C; Chhajed PN; Buitrago-Tellez C; Frei R; Frey M; Tamm M
    Eur Respir J; 2005 Nov; 26(5):767-72. PubMed ID: 16264035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performance of Xpert MTB/RIF for Diagnosis of Tuberculosis in HIV-Infected People in China: A Retrospective, Single-Center Study.
    Gao G; Zhu C; Liu Y; Yang S; Xiao J; Zhao H; Yang D; Liang H; Wang F; Wu L; Zhang F; Ni L
    Med Sci Monit; 2022 Oct; 28():e937264. PubMed ID: 36196026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
    Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
    Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of next-generation sequencing in early diagnosis of patients with tuberculous meningitis.
    Lin A; Cheng B; Han X; Zhang H; Liu X; Liu X
    J Neurol Sci; 2021 Mar; 422():117310. PubMed ID: 33631643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment and clinical utility of metagenomic next-generation sequencing for suspected lower respiratory tract infections.
    Chen H; Huang Q; Wu W; Wang Z; Wang W; Liu Y; Ruan F; He C; Li J; Liu J; Wu G
    Eur J Med Res; 2024 Apr; 29(1):213. PubMed ID: 38561853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
    Kawkitinarong K; Suwanpimolkul G; Kateruttanakul P; Manosuthi W; Ubolyam S; Sophonphan J; Avihingsanon A; Ruxrungtham K
    Clin Infect Dis; 2017 May; 64(suppl_2):S171-S178. PubMed ID: 28475796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Xpert
    Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advancing Microbe Detection for Lower Respiratory Tract Infection Diagnosis and Management with Metagenomic Next-Generation Sequencing.
    Dong Y; Chen Q; Tian B; Li J; Li J; Hu Z
    Infect Drug Resist; 2023; 16():677-694. PubMed ID: 36743335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diagnostic value of detection of pathogens in bronchoalveolar lavage fluid by metagenomics next-generation sequencing in organ transplant patients with pulmonary infection].
    Meng X; Zhang L; Fan X; Fang X; Pan A
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Dec; 33(12):1440-1446. PubMed ID: 35131010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China.
    Li S; Lin L; Zhang F; Zhao C; Meng H; Wang H
    BMC Infect Dis; 2020 May; 20(1):362. PubMed ID: 32448123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid.
    Theron G; Peter J; Meldau R; Khalfey H; Gina P; Matinyena B; Lenders L; Calligaro G; Allwood B; Symons G; Govender U; Setshedi M; Dheda K
    Thorax; 2013 Nov; 68(11):1043-51. PubMed ID: 23811536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India.
    Singh UB; Pandey P; Mehta G; Bhatnagar AK; Mohan A; Goyal V; Ahuja V; Ramachandran R; Sachdeva KS; Samantaray JC
    PLoS One; 2016; 11(2):e0149258. PubMed ID: 26894283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Harnessing Big Data to Optimize an Algorithm for Rapid Diagnosis of Pulmonary Tuberculosis in a Real-World Setting.
    Peng J; Song J; Wang F; Zuo P; Lu Y; Liu W; Tian L; Chen Z; Zhu Y; Wang X; Shen N; Wang X; Wu S; Yu Q; Vallance BA; Jacobson K; Sun Z; Yu HB
    Front Cell Infect Microbiol; 2021; 11():650163. PubMed ID: 33816355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic performance of the Xpert MTB/RIF assay in BAL fluid samples from patients under clinical suspicion of pulmonary tuberculosis: a tertiary care experience in a high-tuberculosis-burden area.
    Brito GMX; Mafort TT; Ribeiro-Alves M; Reis LVTD; Leung J; Leão RS; Rufino R; Rodrigues LS
    J Bras Pneumol; 2021; 47(2):e20200581. PubMed ID: 34008762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of the Xpert Mycobacterium tuberculosis/rifampicin assay for diagnosing sputum-smear negative or sputum-scarce pulmonary tuberculosis in bronchoalveolar lavage fluid.
    Yang J; Shen Y; Wang L; Ju L; Wu X; Wang P; Hao X; Sun Q; Yu F; Sha W
    Int J Infect Dis; 2021 Jun; 107():121-126. PubMed ID: 33864923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.